GT Biopharma, Inc. (GTBP)
0.64
-0.01
(-1.45%)
USD |
NASDAQ |
Dec 09, 16:00
0.6399
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Total Liabilities (Quarterly): 1.321M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 13.62M |
| Geron Corp. | 318.68M |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| SELLAS Life Sciences Group, Inc. | 5.925M |
| Xencor, Inc. | 243.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.321M |
| Shareholders Equity (Quarterly) | 3.00M |
| Current Ratio | 2.696 |